Related Experiment Video
Updated: Jul 14, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Relationship between homocysteine and chronic total coronary occlusion: a cross-sectional study from southwest China
Kaiyong Xiao1, Zhe Xv2, Liang Liu3
1Department of Cardiology, Guangyuan Central Hospital, Guangyuan, SC, China.
Insights
Elevated homocysteine levels are significantly linked to chronic total coronary occlusion, a complex heart condition. This association is particularly strong in older individuals and those with diabetes or hypertension.
Area of Science:
- Cardiology
- Biochemistry
- Public Health
Background:
- Chronic total coronary occlusion (CTO) represents a complex challenge in cardiovascular medicine.
- Elevated homocysteine is a known risk factor for coronary artery diseases, but its specific role in CTO requires further investigation.
Purpose of the Study:
- To investigate the association between homocysteine levels and the prevalence of chronic total coronary occlusion in a Chinese population.
- To identify whether homocysteine is an independent risk factor for CTO.
Main Methods:
- A study involving 1295 individuals from Southwest China.
- Analysis of homocysteine levels divided into quartiles, with CTO defined as >3 months of complete coronary artery occlusion.
- Statistical methods included logistic regression, ROC curves, and subgroup analyses.
Main Results:
- Higher homocysteine quartiles correlated with increased rates of CTO (P < 0.001).
- Elevated homocysteine (≥ 15.2 μmol/L) was an independent predictor of CTO (OR 1.53, P=0.0265).
- The association was more pronounced in elderly individuals and those with hypertension and diabetes.
Conclusions:
- Elevated homocysteine is significantly associated with chronic total coronary occlusion.
- Homocysteine serves as an independent indicator for CTO, especially in vulnerable subgroups like the elderly and patients with comorbidities.
Background:
Chronic total coronary occlusion is among the most complex coronary artery diseases. Elevated homocysteine is a risk factor for coronary artery diseases. However, few studies have assessed the relationship between homocysteine and chronic total coronary occlusion.
Methods:
1295 individuals from Southwest China were enrolled in the study. Chronic total coronary occlusion was defined as complete occlusion of coronary artery for more than three months. Homocysteine was divided into quartiles according to its level. Univariate and multivariate logistic regression models, receiver operating characteristic curves, and subgroup analysis were applied to assess the relationship between homocysteine and chronic total coronary occlusion.
Results:
Subjects in the higher homocysteine quartile had a higher rate of chronic total coronary occlusion (P < 0.001). After adjustment, the odds ratio for chronic total coronary occlusion in the highest quartile of homocysteine compared with the lowest was 1.918 (95% confidence interval 1.237-2.972). Homocysteine ≥ 15.2 μmol/L was considered an independent indicator of chronic total coronary occlusion (odds ratio 1.53, 95% confidence interval 1.05-2.23; P = 0.0265). The area under the receiver operating characteristic curve was 0.659 (95% confidence interval, 0.618-0.701; P < 0.001). Stronger associations were observed in elderly and in those with hypertension and diabetes.
Conclusions:
Elevated homocysteine is significantly associated with chronic total coronary occlusion, particularly in elderly and those with hypertension and diabetes.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures

